These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 25743216)

  • 21. Synthesis and anti-proliferative activity of a novel 1,2,3-triazole tethered chalcone acetamide derivatives.
    Vanaparthi S; Bantu R; Jain N; Janardhan S; Nagarapu L
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127304. PubMed ID: 32631524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
    Gong Z; Xie Z; Qiu J; Wang G
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel carbapenem chalcone derivatives: synthesis, cytotoxicity and molecular docking studies.
    Kommidi DR; Pagadala R; Rana S; Singh P; Shintre SA; Koorbanally NA; Jonnalagadda SB; Moodley B
    Org Biomol Chem; 2015 Apr; 13(14):4344-50. PubMed ID: 25767041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro α-Glucosidase Inhibition by Non-sugar based Triazoles of Dibenzoazepine, their Structure-Activity Relationship, and Molecular Docking.
    Khan MA; Javaid K; Wadood A; Jamal A; Batool F; Fazal-Ur-Rehman S; Basha FZ; Choudhary MI
    Med Chem; 2017; 13(7):698-704. PubMed ID: 28745232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones.
    Sun H; Li Y; Zhang X; Lei Y; Ding W; Zhao X; Wang H; Song X; Yao Q; Zhang Y; Ma Y; Wang R; Zhu T; Yu P
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4567-71. PubMed ID: 26351039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents.
    Alam R; Wahi D; Singh R; Sinha D; Tandon V; Grover A; Rahisuddin
    Bioorg Chem; 2016 Dec; 69():77-90. PubMed ID: 27744115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.
    Nikookar H; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Ranjbar PR; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of friedelan triterpenoid analogs with DNA topoisomerase IIα inhibitory activity and their molecular docking studies.
    Mandal A; Ghosh S; Bothra AK; Nanda AK; Ghosh P
    Eur J Med Chem; 2012 Aug; 54():137-43. PubMed ID: 22633831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
    Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
    Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of the novel DNA topoisomerase II inhibitors: esterification and amination substituted 4'-demethylepipodophyllotoxin derivates exhibiting anti-tumor activity by activating ATM/ATR signaling pathways.
    Xiao L; Zhao W; Li HM; Wan DJ; Li DS; Chen T; Tang YJ
    Eur J Med Chem; 2014 Jun; 80():267-77. PubMed ID: 24793877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
    Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring.
    Chinthala Y; Kumar Domatti A; Sarfaraz A; Singh SP; Kumar Arigari N; Gupta N; Satya SK; Kotesh Kumar J; Khan F; Tiwari AK; Paramjit G
    Eur J Med Chem; 2013; 70():308-14. PubMed ID: 24177357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
    Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
    Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity.
    Baviskar AT; Banerjee UC; Gupta M; Singh R; Kumar S; Gupta MK; Kumar S; Raut SK; Khullar M; Singh S; Kumar R
    Bioorg Med Chem; 2013 Sep; 21(18):5782-93. PubMed ID: 23920485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 2-acylbenzofuranes as novel α-glucosidase inhibitors with hypoglycemic activity.
    Spasov AA; Babkov DA; Prokhorova TY; Sturova EA; Muleeva DR; Demidov MR; Osipov DV; Osyanin VA; Klimochkin YN
    Chem Biol Drug Des; 2017 Dec; 90(6):1184-1189. PubMed ID: 28585419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.